• Webshop
  • Events
  • Newsletter
  • Literature
  • blog
biocrates life sciences ag
  • Home
  • Why Metabolomics
  • Applications
    • Applications overview
    • Microbiome
    • Nutrition & wellbeing
    • Neurology
    • Infectious disease and COVID-19
  • Products
    • Our Technology
    • Targeted profiling kits
    • MxP® Quant 500 XL
    • MxP® Quant 500
    • MxP® Quant HR Xpress™
    • AbsoluteIDQ® p400 HR
    • AbsoluteIDQ® p180
    • Pathway specific kits
    • AbsoluteIDQ® Stero17
    • AbsoluteIDQ® Bile Acids
    • Quantitative metabolomics database (QMDB)
    • WebIDQ Software
  • Services
    • Metabolomics phenotyping
    • Data analysis and biostatistics
    • Pathway analysis
    • Certified laboratories
  • About us
    • About us
    • Careers
  • Contact
    • Contact us
    • Support
    • Distribution partners
Select Page

metabolites

Categories

  • Animal Health (5)
  • Blog (55)
  • Cardiology (5)
  • Cardiometabolic disease (20)
  • Cardiovascular disease (5)
  • Commentary (2)
  • Data analysis (3)
  • Enterosynes (2)
  • Epidemiology (17)
  • Gastroenterology (3)
  • Hepatology (9)
  • Infectiology (12)
  • Literature (89)
  • Metabolite of the month (24)
  • Microbiome (23)
  • Neurology (28)
  • Nutrition (14)
  • Oncology (14)
  • Pharmacology (13)
  • Prebiotics (1)

Featured Posts

  • “Pan-cohort studies – the future of population health” symposium
  • 7 questions for first metabolomics project
  • Which sample matrix should I use for metabolomics study?
  • Importance of pre-analytics for metabolomics studies
  • 20 years celebration of biocrates
  • biocrates Podcast
  • Could metabolites enhance pharmacological cancer treatments?
  • Is Alzheimer’s a metabolic disease?
  • Metabolic interaction of COVID-19 and metabolic diseases